Genmab announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (... Jan 16
Cami is currently being investigated in a pivotal phase 2 clinical trial with 100 patients... Nov 02
The pivotal trial is event-based and there are many variables that will ultimately impact read-out timing... Sep 14
-Advertisements-